Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
ORIGINAL ARTICLE
Open Access
oa
Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Japanese Patients With Plaque Psoriasis: In-Depth Analysis of Efficacy and Safety in the Phase 3 POETYK PSO-4 Trial
- Pages: 953-966
- First Published: 30 April 2025
Open Access
oa
Real-world safety and effectiveness of guselkumab in patients with psoriasis: A post-marketing surveillance study through up to week 52 in Japan
- Pages: 967-982
- First Published: 29 March 2025
Open Access
oa
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study
- Pages: 983-1000
- First Published: 16 April 2025
Open Access
oa
HLA-B51 Positivity Correlates With Symptom Completeness From Recurrent Aphthous Stomatitis to Complete Behçet's Disease
- Pages: 1001-1007
- First Published: 21 April 2025
no
Vitiligo associated with type 2 immune inhibitors: FAERS analysis and literature review
- Pages: 1008-1014
- First Published: 15 March 2025
no
Comparing immunopathogenesis of non-human immunodeficiency virus immune reconstitution inflammatory syndrome and immune-related adverse events: A prospective multicenter cohort study
- Pages: 1015-1030
- First Published: 29 March 2025
no
Impact of shared decision-making in onychomycosis treatment: A cross-sectional study based on the Illuminating Dialogues and Insights in Onychomycosis Management (IDIOM) survey
- Pages: 1031-1038
- First Published: 26 March 2025
no
Disease burden and treatment preference for moderate-to-severe atopic dermatitis in Taiwan: A discrete-choice experiment
- Pages: 1039-1047
- First Published: 26 March 2025
no
Increased Incidence of COVID-19 Infection in Atopic Dermatitis Patients: A Real-World Cohort Study With Risk Factor Analysis
- Pages: 1048-1058
- First Published: 12 April 2025
CONCISE COMMUNICATION
Open Access
oa
Clinical Characteristics and Safety Profiles of Japanese Psoriasis Patients Who Continued Apremilast Treatment for 6 and 12 Months: A Post Hoc Analysis of an Apremilast Postmarketing Surveillance Study
- Pages: 1059-1065
- First Published: 10 May 2025
Open Access
oa
A Case of Stevens–Johnson Syndrome Induced by Selpercatinib
- Pages: 1066-1069
- First Published: 16 April 2025
Open Access
oa
Elevated Serum Immunoglobulin G1 Levels and Left Ventricular Diastolic Dysfunction in Anti-Centromere Antibody–Positive Patients With Lower Extremity Arterial Disease: A Cross-Sectional Study
- Pages: 1070-1077
- First Published: 16 May 2025
no
The importance of pseudohyperchloremia for the diagnosis of bromoderma
- Pages: 1078-1082
- First Published: 20 March 2025
no
Persistent exanthema mainly on the trunk with pathologically dermal interstitial mucin as anti-HMGCR myopathy-associated skin rash: Case series
- Pages: 1083-1089
- First Published: 28 March 2025
no
Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment
- Pages: 1090-1093
- First Published: 25 March 2025
no
Transurethral resection and oral mucosal grafting for urethral-involved extramammary Paget disease: A function-preserving approach
- Pages: 1094-1097
- First Published: 26 March 2025
no
Serum circulating S100A7 and S100A15 DNA copies are elevated in patients with psoriasis and atopic dermatitis
- Pages: 1098-1102
- First Published: 01 April 2025
no
A novel LSS variant leading to hypotrichosis with pseudoainhum
- Pages: 1103-1106
- First Published: 16 April 2025
no
Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T-Cell Lymphoma: A Real-World Single-Center Experience
- Pages: 1107-1112
- First Published: 16 April 2025
no
Effects of Guselkumab on the FIB-4 Index in Psoriasis Patients (EGIPT): A Three-Year Study
- Pages: 1113-1117
- First Published: 16 April 2025
RESEARCH NOTE
no
Active Switch From a Single Dose of Bimekizumab to Risankizumab in Psoriasis: A Pilot Study
- Pages: 1118-1120
- First Published: 22 April 2025
CORRECTION
Free Access
free
Correction to “Clinical Background of Patients With Psoriasiform Skin Lesions due to Tumor Necrosis Factor Antagonist Administration at a Single Center”
- Page: 1121
- First Published: 27 April 2025
ISSUE INFORMATION
GUIDELINES
Free Access
free
Wound, pressure ulcer, and burn guidelines – 3: Guidelines for the diagnosis and treatment of diabetic ulcers and gangrene, second edition
- Pages: e391-e429
- First Published: 28 April 2025
Open Access
oa
Wound, pressure ulcer, and burn guidelines (2023)―4: Guidelines for the management of connective tissue disease/vasculitis-associated skin ulcers, third edition
- Pages: e430-e480
- First Published: 28 April 2025
Free Access
free
Wound, Pressure Ulcer and Burn Guidelines (2023)―5: Guidelines for the Management of Lower Leg Ulcers/Varicose Veins, Third Edition Wound/Pressure Ulcer/Burn Guidelines Drafting Committee (Lower Leg Ulcers/Varicose Veins Group)
- Pages: e481-e528
- First Published: 30 April 2025
LETTER TO THE EDITOR
Open Access
oa
Multiple Mucous Cysts on the Hands of a Patient With Systemic Sclerosis Treated With Collagen Sheets for Scar Healing
- Pages: e529-e530
- First Published: 28 April 2025
no
A case of non-uremic calciphylaxis in a patient with secondary hyperparathyroidism and panhypopituitarism
- Pages: e531-e533
- First Published: 04 February 2025
no
Klebsiella pneumoniae bacteremic cellulitis following tocilizumab administration for COVID-19
- Pages: e534-e535
- First Published: 06 February 2025
no
Treating tislelizumab-induced ulcerative lichenoid drug eruption with baricitinib in a patient with lung cancer
- Pages: e536-e537
- First Published: 07 February 2025
no
A case of epidermal growth factor receptor–mutant lung cancer with transformation from adenocarcinoma into small cell carcinoma suggested by histological investigation of skin metastasis
- Pages: e538-e540
- First Published: 11 February 2025
no
Histopathological findings of dermatophytoma using the alginate method: Investigating the potential for mixed infections of fungi and cocci beneath the nail bed
- Pages: e541-e542
- First Published: 11 February 2025
no
A case of exacerbation of radiation-induced ulceration after bullous pemphigoid onset
- Pages: e543-e545
- First Published: 11 February 2025
no
Concurrent wild-type transthyretin amyloidosis and psoriasis vulgaris in an elderly man
- Pages: e546-e547
- First Published: 07 February 2025
no
Occurrence of bullous pemphigoid during long-term maintenance treatment for pemphigus vulgaris in remission
- Pages: e548-e550
- First Published: 25 March 2025
no
Exacerbation of dipeptidyl peptidase-IV inhibitor-associated bullous pemphigoid by the immune checkpoint inhibitors durvalumab and tremelimumab
- Pages: e551-e552
- First Published: 14 February 2025
no
Cochineal allergy confirmed by specific IgE testing: Review of diagnostic sensitivity
- Pages: e553-e554
- First Published: 20 February 2025
no
Anaphylaxis triggered by dog contact and exhaustion in a dog-allergic patient with atopic dermatitis
- Pages: e555-e556
- First Published: 17 February 2025
no
Efficacy of intralesional bleomycin therapy for recalcitrant plantar warts: A retrospective case series of 50 patients
- Pages: e557-e558
- First Published: 10 March 2025
no
Increased circulating interleukin 36γ DNA copies in psoriasis
- Pages: e559-e560
- First Published: 20 February 2025
no
Immediate and sustained efficacy of nemolizumab in chronic pruritus of unknown origin
- Pages: e561-e562
- First Published: 22 February 2025
no
Successful treatment of lymphocutaneous sporotrichosis with fosravuconazole
- Pages: e563-e564
- First Published: 28 February 2025
no
A case of systemic sclerosis accompanying psoriasis successfully treated with brodalumab
- Pages: e565-e566
- First Published: 26 February 2025
no
Case of allergic contact dermatitis caused by polyurethane elastic cannula
- Pages: e567-e569
- First Published: 05 March 2025
no
Recalcitrant primary extramammary scrotal Paget disease in a patient with prostate cancer and May-Hegglin anomaly treated successfully with Rhenium-188 (188Re) brachytherapy
- Pages: e570-e571
- First Published: 11 March 2025
no
Multiple pyogenic granulomas on arteriovenous malformation associated with NRAS mutation
- Pages: e572-e574
- First Published: 12 March 2025
no
Alopecia universalis and type 1 diabetes mellitus both successfully controlled with baricitinib in a patient with autoimmune polyglandular syndrome type 3A
- Pages: e575-e577
- First Published: 17 March 2025
no
Cutaneous inflammation with upregulated interleukin-36γ and TNFα in a patient with loricrin keratoderma
- Pages: e578-e579
- First Published: 19 March 2025
no
A unique case of systemic lupus erythematosus presenting with interstitial granulomatous dermatitis at onset and palisaded neutrophilic granulomatous dermatitis at relapse
- Pages: e580-e581
- First Published: 14 March 2025
no
Pachydermoperiostosis successfully treated with celecoxib
- Pages: e582-e583
- First Published: 25 March 2025
no
Hypopigmented malignant melanoma in a patient with oculocutaneous albinism type 4
- Pages: e584-e585
- First Published: 20 March 2025